{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:51Z","timestamp":1791475371457,"version":"4.3.4"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is often associated with insulin resistance (IR). The role of prolactin (PRL) in this context remains unclear, particularly across different PCOS phenotypes. The aim of this study was to investigate the distribution of PRL, as well as its correlation with basal IR in women with PCOS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>200 women with PCOS, evenly distributed across phenotypes A-D and matched for age and body mass index (BMI) were retrospectively analyzed. PRL, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), sexual hormone binding globulin (SHBG), testosterone, and BMI were assessed. Correlation analysis and unsupervised clustering (based on PRL and HOMA-IR) were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PRL levels were similar across phenotypes, but phenotype D had a significantly lower prevalence of HOMA-IR \u2265 2.5 (p = 0.032). PRL was inversely correlated with HOMA-IR in all groups (p &amp;lt; 0.05). Cluster analysis identified three distinct subgroups, independent of phenotype, differing significantly in both PRL and HOMA-IR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>PRL is inversely associated with IR in PCOS, regardless of phenotype. Cluster analysis reveals metabolic subtypes not captured by current phenotype-based classification, suggesting potential for improved risk stratification.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1674795","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:17:14Z","timestamp":1759292234000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Distribution of prolactin and its correlation with insulin resistance in women with polycystic ovary syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Stefan","family":"Ghobrial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krysiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Patsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Paternostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Heinzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertility Sterility"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.01.032","article-title":"Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria","volume":"88","author":"Shroff","year":"2007","journal-title":"Fertil Steril"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3464","article-title":"Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome","volume":"38","author":"Krentowska","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/jcm10040829","article-title":"Risk of insulin resistance and metabolic syndrome in women with hyperandrogenemia: A comparison between PCOS phenotypes and beyond","volume":"10","author":"Borzan","year":"2021","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_30_19","article-title":"Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene","volume":"23","author":"Sachdeva","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2017.0055","article-title":"The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS","volume":"88","author":"Altintas","year":"2017","journal-title":"Ginekol Pol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13104-018-3207-y","article-title":"The correlation between serum AMH and HOMA-IR among PCOS phenotypes","volume":"11","author":"Wiweko","year":"2018","journal-title":"BMC Res Notes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1613640","article-title":"Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes \u2013 a cross-sectional study","volume":"35","author":"Gupta","year":"2019","journal-title":"Gynecological Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.03.007","article-title":"Serum AMH levels and insulin resistance in women with PCOS","volume":"224","author":"Sahmay","year":"2018","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-3-460","article-title":"Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin","volume":"67","author":"Plymate","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.121400","article-title":"Hyperprolactinemia","volume":"6","author":"Majumdar","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1179558119871921","DOI":"10.1177\/1179558119871921","article-title":"PCOS and Hyperprolactinemia: what do we know in 2019","volume":"13","author":"Delcour","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347025","article-title":"Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome","volume":"26","author":"Bahceci","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00263","article-title":"The association between prolactin and metabolic parameters in PCOS women: A retrospective analysis","volume":"11","author":"Yang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1001703","article-title":"The beneficial metabolic actions of prolactin","volume":"13","author":"Macotela","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0306-4530(02)00112-9","article-title":"Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"167132","DOI":"10.1155\/2012\/167132","article-title":"Macroprolactinemia: diagnostic, clinical, and pathogenic significance","volume":"2012","author":"Shimatsu","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13048-019-0564-7","article-title":"Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study","volume":"12","author":"Hager","year":"2019","journal-title":"J Ovarian Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2523","article-title":"Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome","volume":"100","author":"M\u00fcnzker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-021-00535-0","article-title":"Evaluation of the efficacy of sex hormone-binding globulin in insulin resistance assessment based on HOMA-IR in patients with PCOS","volume":"28","author":"Chen","year":"2021","journal-title":"Reprod Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.1981.10479327","article-title":"Rank transformations as a bridge between parametric and nonparametric statistics","volume":"35","author":"Conover","year":"1981","journal-title":"Am Statistician"},{"key":"B28","doi-asserted-by":"publisher","first-page":"107190","DOI":"10.1016\/j.csda.2021.107190","article-title":"Clustering with the average silhouette width","volume":"158","author":"Batool","year":"2021","journal-title":"Comput Stat Data Analysis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-4755-12-7","article-title":"A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria","volume":"12","author":"Jamil","year":"2015","journal-title":"Reprod Health"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07408-2","article-title":"PCOS phenotype focus: phenotype D under the magnifying glass","volume":"309","author":"Myers","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1370578","article-title":"Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome","volume":"15","author":"Wen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.571229","article-title":"Prolactin is associated with insulin resistance and beta-cell dysfunction in infertile women with polycystic ovary syndrome","volume":"12","author":"Yang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-448-3_15","article-title":"Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo","volume":"560","author":"Kim","year":"2009","journal-title":"Methods Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22699","article-title":"Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome-Based on liquid chromatography with tandem mass spectrometry measurements","volume":"33","author":"Yang","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"B36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/endoabs.90.P471","article-title":"Establishing LOQ for estradiol, LH, FSH and testosterone on Roche Cobas e801","volume":"90","author":"Goreta","year":"2023","journal-title":"Endocrine Abstracts"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1674795\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:17:14Z","timestamp":1759292234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1674795\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":36,"alternative-id":["10.3389\/fendo.2025.1674795"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1674795","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"1674795"}}